We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
VERU icon
426
Veru
VERU
$36M
$36M $2.24 0.9%
ENLV icon
427
Enlivex Ltd
ENLV
$35.2M
$35.2M $2.09 7.18%
NTRB icon
428
Nutriband
NTRB
$34.6M
$34.6M $2.85 2.06%
GRCE
429
Grace Therapeutics
GRCE
$33.8M
$33.8M $2.08 0.48%
LTRN icon
430
Lantern Pharma
LTRN
$33.6M
$33.6M $2.63 0.75%
LITS
431
Lite Strategy Inc
LITS
$32.8M
$32.8M $0.9635 2.4%
ESLA icon
432
Estrella Immunopharma
ESLA
$30.7M
$30.7M $0.7137 0.89%
BCTX
433
Briacell Therapeutics
BCTX
$29.9M
$29.9M $3.44 5.23%
TVGN icon
434
Tevogen Inc. Common Stock
TVGN
$29.7M
$29.7M $7.05 4.91%
KYNB
435
Kyntra Bio
KYNB
$27.2M
$27.2M $6.73 0.88%
PSTV icon
436
Plus Therapeutics
PSTV
$26.6M
$26.6M $3.87 6.03%
ACTU
437
Actuate Therapeutics
ACTU
$26.6M
$26.6M $1.11 5.13%
ABVC icon
438
ABVC BioPharma
ABVC
$26.3M
$26.3M $1.01 6.48%
ALGS icon
439
Aligos Therapeutics
ALGS
$26.2M
$26.2M $4.23 2.08%
RADX
440
Radiopharm Theranostics
RADX
$24.8M
$24.8M $3.15 1.56%
CRVO icon
441
CervoMed
CRVO
$23.9M
$23.9M $2.58 2.38%
EVAX
442
Evaxion A/S
EVAX
$23.5M
$23.5M $2.82 0.35%
PLRZ
443
Polyrizon Ltd
PLRZ
$23.4M
$23.4M $11.25 3.18%
YARW
444
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
$23.4M $35.02 6.15%
QNCX icon
445
Quince Therapeutics
QNCX
$22.9M
$22.9M $23.39 1.56%
BRNS
446
Barinthus Biotherapeutics
BRNS
$22.8M
$22.8M $0.5578 0.14%
LGVN
447
Longeveron
LGVN
$22.2M
$22.2M $0.7015 3.88%
NEUP
448
Neuphoria Therapeutics
NEUP
$21M
$21M $3.88 1.02%
JSPR icon
449
Jasper Therapeutics
JSPR
$21M
$21M $0.6300 1.48%
ATOS icon
450
Atossa Therapeutics
ATOS
$20.6M
$20.6M $2.07 5.48%
16 17
18
19 20

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 566 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.2T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $121B, Regeneron Pharmaceuticals (REGN) at $78.5B and argenx (ARGX) at $53.4B.

Among institutional investors, Atrium Therapeutics (RNA) drew the most net new fund positions in Q1 2026: 162 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.